JANX
Price
$40.62
Change
+$0.01 (+0.02%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
2.38B
49 days until earnings call
LGND
Price
$111.89
Change
+$0.81 (+0.73%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
2.1B
20 days until earnings call
Ad is loading...

JANX vs LGND

Header iconJANX vs LGND Comparison
Open Charts JANX vs LGNDBanner chart's image
Janux Therapeutics
Price$40.62
Change+$0.01 (+0.02%)
Volume$12.28K
Capitalization2.38B
Ligand Pharmaceuticals
Price$111.89
Change+$0.81 (+0.73%)
Volume$10.57K
Capitalization2.1B
JANX vs LGND Comparison Chart
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. LGND commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and LGND is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (JANX: $40.61 vs. LGND: $111.08)
Brand notoriety: JANX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 69% vs. LGND: 62%
Market capitalization -- JANX: $2.38B vs. LGND: $2.1B
JANX [@Biotechnology] is valued at $2.38B. LGND’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $370.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, both JANX and LGND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 5 bearish.
  • LGND’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, LGND is a better buy in the short-term than JANX.

Price Growth

JANX (@Biotechnology) experienced а -20.09% price change this week, while LGND (@Biotechnology) price change was +0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

JANX is expected to report earnings on May 13, 2025.

LGND is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($2.38B) has a higher market cap than LGND($2.1B). LGND YTD gains are higher at: 3.668 vs. JANX (-24.150). LGND has higher annual earnings (EBITDA): 95.8M vs. JANX (-83.88M). JANX has more cash in the bank: 658M vs. LGND (220M). LGND has less debt than JANX: LGND (7.36M) vs JANX (23.4M). LGND has higher revenues than JANX: LGND (152M) vs JANX (13M).
JANXLGNDJANX / LGND
Capitalization2.38B2.1B113%
EBITDA-83.88M95.8M-88%
Gain YTD-24.1503.668-658%
P/E RatioN/A44.61-
Revenue13M152M9%
Total Cash658M220M299%
Total Debt23.4M7.36M318%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXLGND
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
70%
Advances
ODDS (%)
Bullish Trend 29 days ago
88%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
72%
View a ticker or compare two or three
Ad is loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-7.56%
VKTX - JANX
61%
Loosely correlated
-6.60%
DNLI - JANX
47%
Loosely correlated
+0.79%
LGND - JANX
41%
Loosely correlated
+0.73%
CDXS - JANX
39%
Loosely correlated
+1.03%
SKYE - JANX
38%
Loosely correlated
-4.26%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with DNLI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+0.73%
DNLI - LGND
54%
Loosely correlated
+0.79%
VKTX - LGND
45%
Loosely correlated
-6.60%
JANX - LGND
41%
Loosely correlated
-7.56%
ACLX - LGND
39%
Loosely correlated
-0.74%
BEAM - LGND
38%
Loosely correlated
+0.04%
More